We’ve been writing about retractions for six years, and things tend to fall into easily recognizable categories — plagiarism, fabricated data, rigged peer review, etc.
So it’s always interesting to come across a notice sui generis, such as one that appeared in July in OncoTargets and Therapy, a Dove title, about a new way to detect tumor markers.
According to the retraction notice:
Continue reading Beg pardon? Researchers pull cancer paper because, well, um, you see …